BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toth K, Nagi K, Slosky LM, Rochelle L, Ray C, Kaur S, Shenoy SK, Caron MG, Barak LS. Encoding the β-Arrestin Trafficking Fate of Ghrelin Receptor GHSR1a: C-Tail-Independent Molecular Determinants in GPCRs. ACS Pharmacol Transl Sci 2019;2:230-46. [PMID: 32259059 DOI: 10.1021/acsptsci.9b00018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Rouault AAJ, Buscaglia P, Sebag JA. MRAP2 inhibits β-arrestin recruitment to the ghrelin receptor by preventing GHSR1a phosphorylation. J Biol Chem 2022;298:102057. [PMID: 35605660 DOI: 10.1016/j.jbc.2022.102057] [Reference Citation Analysis]
2 Gross JD, Kim DW, Zhou Y, Jansen D, Slosky LM, Clark NB, Ray CR, Hu X, Southall N, Wang A, Xu X, Barnaeva E, Wetsel WC, Ferrer M, Marugan JJ, Caron MG, Barak LS, Toth K. Discovery of a functionally selective ghrelin receptor (GHSR1a) ligand for modulating brain dopamine. Proc Natl Acad Sci U S A 2022;119:e2112397119. [PMID: 35239443 DOI: 10.1073/pnas.2112397119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nagi K, Onaran HO. Biased agonism at G protein-coupled receptors. Cell Signal 2021;83:109981. [PMID: 33744417 DOI: 10.1016/j.cellsig.2021.109981] [Reference Citation Analysis]
4 Nagi K, Habib AM. Biased signaling: A viable strategy to drug ghrelin receptors for the treatment of obesity. Cell Signal 2021;83:109976. [PMID: 33713808 DOI: 10.1016/j.cellsig.2021.109976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]